Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • June 13, 2019 8:57 AM | Grant Dvorak (Administrator)

    June 13, 2019, MedPage Today 

    New surgical techniques may address the recently reported safety issues associated with laparoscopic radical hysterectomy for early-stage cervical cancer, researchers found.

    Read more.

  • June 12, 2019 9:03 AM | Grant Dvorak (Administrator)

    June 12, 2019, Medscape 

    Rates of nonsuicidal self-harm (NSSH) are rising, especially among adolescent girls and young adult women. Few of these people receive medical or psychological help, new research suggests. 

    Read more.

  • June 11, 2019 8:39 AM | Grant Dvorak (Administrator)

    June 11, 2019, JAAPA 

    Ample resources exist detailing the variety of contraceptive options for patients who want to prevent an unintended pregnancy; however, few resources provide tools to guide clinicians in best practices for history taking and patient education about contraceptive use. This article attempts to fill this gap by reviewing current recommendations on timing of patient education, techniques to open a discussion, and common patient misunderstandings about pregnancy and contraception. 

    Read more.

  • June 07, 2019 7:41 AM | Grant Dvorak (Administrator)

    June 7, 2019, HealthDay News

    THURSDAY, June 6, 2019 (HealthDay News) -- Wendy Lybarger lived an hour's drive from the hospital where her breast cancer would be treated, so she was looking forward to a heaping helping of hassle.

    For as many as six weeks, she'd have to travel there every weekday to receive radiation treatments after surgery to remove the small lump in her breast.

    Read more.
  • June 04, 2019 9:01 AM | Grant Dvorak (Administrator)

    June 4, 2019, Medscape 

    Both passive and active thoughts of suicide occur concurrently in a subset of women with premenstrual syndrome, new research suggests. The findings were presented at the American Society of Clinical Psychopharmacology (ASCP) 2019 annual meeting. 

    Read more.

  • June 04, 2019 8:59 AM | Grant Dvorak (Administrator)

    June 4, 2019, Medscape 

    It's not often that a systemic oral therapy significantly improves overall survival (OS) in the setting of metastatic cancer. And, in the case of CDK4/6 inhibitors for breast cancer, it was looking like one might not do so, as multiple previous trials were limited to a significant improvement in progression-free survival.

    Read more.

  • June 04, 2019 8:57 AM | Grant Dvorak (Administrator)

     June 4, 2019, HemOnc Today  

    Data from two trials evaluating the safety and efficacy of adoptive cell transfer with autologous tumor-infiltrating lymphocytes showed promising overall response rates for the treatment of advanced metastatic melanoma and cervical cancer, according to results presented at ASCO Annual Meeting. 

    Read more.

  • June 03, 2019 8:50 AM | Grant Dvorak (Administrator)

    June 3, 2019, MedPage Today 

    CHICAGO -- Adding ribociclib (Kisqali) to endocrine therapy significantly prolonged survival in women with advanced HR-positive/HER-negative breast cancer, with a 29% lower risk of death, a researcher reported here. 

    Read more.

  • May 28, 2019 8:59 AM | Grant Dvorak (Administrator)

    May 28, 2019, MedPage Today 

    Among all U.S. women, rates of more aggressive non-endometrioid cancer subtypes have been rising rapidly. And trends show marked racial differences and disparities, with higher rates of uterine corpus subtypes and poorer survival among non-Hispanic black women, according to a new study in the Journal of Clinical Oncology.

    Read more.

  • May 28, 2019 8:57 AM | Grant Dvorak (Administrator)

    May 28, 2019, MedPage Today 

    Two diagnostic tests for gonorrhea and chlamydia infection may be used with throat and rectal samples, the U.S. Food and Drug Administration said on May 23. Hologic's Aptima Combo 2 Assay and the Cepheid Xpert CT/NG had previously been cleared for diagnostic testing to detect Chlamydia trachomatis and Neisseria gonorrhoeae in urine, vaginal and endocervical samples. The FDA noted that no chlamydia or gonorrhea tests had been cleared for use on samples from the throat and rectum. 

    Read more.

Powered by Wild Apricot Membership Software